Trends like cortisol and NAD+ supplements highlight a desire to address stress, energy and cellular health at a foundational level, signalling a shift towards internal optimisation
The lower dose used to treat diabetes carries an average retail price of nearly $1,000 a month
It established two cohorts: 244,063 patients in the GLP-1 RA treatment group (Victoza, Saxenda, Ozempic, Wegovy) and 11,439,560 patients in the non-GLP-1 RA group
Download My One-Page Guide to Retatrutide
Losing weight depends on person to person
The combination addresses appetite, food reward, gastric emptying, and insulin sensitivity through a broader receptor engagement than GLP-1 agonism alone